0 212

Cited 14 times in

Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy

DC FieldValueLanguage
dc.contributor.author금기창-
dc.contributor.author윤진숙-
dc.contributor.author임형택-
dc.date.accessioned2017-10-26T07:21:40Z-
dc.date.available2017-10-26T07:21:40Z-
dc.date.issued2016-
dc.identifier.issn0721-832X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/151929-
dc.description.abstractPURPOSE: To compare the efficacy and safety of combination therapy with orbital irradiation and systemic steroids versus steroid monotherapy in the management of active Graves' orbitopathy (GO). METHODS: The clinical charts of 127 patients with active inflammation due to GO who received intravenous steroid pulse therapy as a first-line treatment with or without orbital radiotherapy between 2010 and 2014 were reviewed. Patients were divided into two treatment groups: 1) combined orbital radiotherapy and steroid pulse therapy (SRT group) and 2) steroid pulse therapy only (ST group). Primary outcome measures included clinical activity score (CAS); NOSPECS classification; ocular motility impairment; and exophthalmos at 1, 3, 6, and 12 months after treatment. The secondary outcome measure was the change in orbital, extraocular muscle (EOM), and fat volume after treatment measured by orbit computed tomography. RESULTS: Sixty-eight patients were included in the SRT group, and 59 patients were in the ST group. In both treatments, CAS and NOSPECS were significantly reduced. In the comparison of the degree of change from baseline between the groups, the SRT group demonstrated more improvement in NOSPECS and scores of ocular motility. Orbital, EOM, and fat volume significantly decreased in the SRT group; however, only fat volume was reduced in the ST group. Compressive optic neuropathy after treatment developed in 0 % of the SRT group and 3.4 % (2/59) of the ST group. Reactivation of inflammation occurred in 11.8 % (8/68) of the SRT group and 28.8 % (17/59) of the ST group. CONCLUSIONS: Orbital radiotherapy in combination with steroid treatment significantly improved ocular motility by reducing EOM volume in patients with active GO.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish, German-
dc.publisherSpringer-Verlag-
dc.relation.isPartOfGRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHCombined Modality Therapy-
dc.subject.MESHDose Fractionation-
dc.subject.MESHExophthalmos/physiopathology-
dc.subject.MESHFemale-
dc.subject.MESHGlucocorticoids/administration & dosage*-
dc.subject.MESHGraves Ophthalmopathy/drug therapy*-
dc.subject.MESHGraves Ophthalmopathy/physiopathology-
dc.subject.MESHGraves Ophthalmopathy/radiotherapy*-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMethylprednisolone/administration & dosage*-
dc.subject.MESHMiddle Aged-
dc.subject.MESHOcular Motility Disorders/diagnostic imaging-
dc.subject.MESHOcular Motility Disorders/physiopathology-
dc.subject.MESHOculomotor Muscles/diagnostic imaging-
dc.subject.MESHOculomotor Muscles/physiopathology-
dc.subject.MESHOrbit/diagnostic imaging-
dc.subject.MESHOrbit/radiation effects*-
dc.subject.MESHPulse Therapy, Drug-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHTomography, Optical Coherence-
dc.subject.MESHTreatment Outcome-
dc.titleEfficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy-
dc.typeArticle-
dc.publisher.locationGermany-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Radiation Oncology-
dc.contributor.googleauthorJi Won Kim-
dc.contributor.googleauthorSun Hyup Han-
dc.contributor.googleauthorByeong Jae Son-
dc.contributor.googleauthorTyler Hyungtaek Rim-
dc.contributor.googleauthorKi Chang Keum-
dc.contributor.googleauthorJin Sook Yoon-
dc.identifier.doi10.1007/s00417-016-3280-7-
dc.contributor.localIdA02611-
dc.contributor.localIdA03419-
dc.contributor.localIdA00272-
dc.relation.journalcodeJ00951-
dc.identifier.eissn1435-702X-
dc.identifier.pmid26876240-
dc.identifier.urlhttps://link.springer.com/article/10.1007%2Fs00417-016-3280-7-
dc.subject.keywordGraves’ orbitopathy-
dc.subject.keywordOrbital radiation-
dc.subject.keywordSystemic steroids-
dc.subject.keywordThyroid-associated orbitopathy-
dc.contributor.alternativeNameKeum, Ki Chang-
dc.contributor.alternativeNameYoon, Jin Sook-
dc.contributor.alternativeNameRim, Tyler H. T.-
dc.contributor.affiliatedAuthorYoon, Jin Sook-
dc.contributor.affiliatedAuthorRim, Tyler Hyungtaek-
dc.contributor.affiliatedAuthorKeum, Ki Chang-
dc.citation.volume254-
dc.citation.number5-
dc.citation.startPage991-
dc.citation.endPage998-
dc.identifier.bibliographicCitationGRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, Vol.254(5) : 991-998, 2016-
dc.date.modified2017-10-24-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.